DIA 2013 49th Annual Meeting
Click here to go to the previous page
Stop Moving the Goalposts: A Life Cycle Approach to Risk-based Quality Management in Clinical Development
Track
:
Track 02: Project/Portfolio Management and Strategic Planning
Program Code:
303
Date:
Wednesday, June 26, 2013
Time:
8:00 AM to 9:30 AM
EST
Location:
205B
CHAIR
:
Barbara Leishman, MA (SCHNON), External Business Alliance Leader, F. Hoffmann-La Roche Ltd., Switzerland
SPEAKER
(S):
Barbara Leishman, MA (SCHNON), External Business Alliance Leader, F. Hoffmann-La Roche Ltd., Switzerland Mary Christian, PharmD (SPKNON), Executive Director, Global Regulatory Strategy, Bristol-Myers Squibb Company, United States
Kenneth J. Sprenger, MD (SPKNON), Executive Director, Medicine Team Leader, Pfizer Inc, United States
Description
This session will highlight the value of a product life cycle approach to prospective quality optimization, as opposed to a study-by-study approach, and provide real life experience in the risk-based design and management of a product life cycle.
This session is a part of:
This session is a part of: